期刊文献+

树突状细胞和抗原负载树突状细胞诱导特异性CTL抗肿瘤效应的形态学观察

Morphological observation of anti-tumor effect of CTL induced by DC and antigen-loaded DC
原文传递
导出
摘要 为了给肿瘤的生物学治疗提供形态学基础,试验分离和培养树突状细胞(DC),制备B16黑色素瘤细胞抗原并进行共培养,即为抗原负载树突状细胞(ADC);建立B16黑色素瘤小鼠模型,于瘤周围皮下注射DC和ADC,测量注射前后各组小鼠的瘤体积,比较其抑瘤作用;应用光镜和透射电镜观察DC和ADC诱导特异性CTL抗肿瘤效应的形态学表现。结果表明:试验组DC和ADC诱导机体抗肿瘤效应显著,与对照组相比差异显著(P<0.05);光镜下DC和ADC主要分布在皮下组织、癌组织周围,特别是癌巢周边;透射电镜下与ADC接触的淋巴细胞形态不规则,淋巴细胞与肿瘤细胞密切接触,大量肿瘤细胞凋亡、坏死。 To provide morphological basis for the tumor biological therapy,DCs were separated and cultured,tumor antigen was extracted from B16 melanoma cells by method of freeze thawing,and then they were co-cultured.The co-cultured cells were antigen-loaded DC.The mouse model of B16 melanoma was established,and DC and antigen-loaded DC were injected into the tumor-surrounding tissues.According to the change of tumor volume and the tumor inhibition rates,antitumor effect of CTL induced by DC and ADC was estimated.The morphology of CTL induced by DC and ADC was observed by optical microscopy and electron microscopy.The antitumor effect of CTL induced by DC and ADC was significantly higher in the experimental group than that in the controls respectively (P〈0.05).Tumor inhibition rate of ADC was higher than that of DC (P〈0.05).Under optical microscopy,DC and ADC were mainly gathered in the subcutaneous tissue and the tumor tissue,especially around the cancer nest.Under electron microscopy,morphology of lymphocyte which contacted with the antigen-loaded DC cells was irregular,and contacted closely with the tumor cells.Apoptosis and necrosis of the cells could be widely observed in tumor tissues.It concludes that the anti-tumor effect of CTL induced by ADC is stronger than that by DC.
出处 《黑龙江畜牧兽医》 CAS 北大核心 2010年第6期19-22,共4页 Heilongjiang Animal Science And veterinary Medicine
基金 黑龙江省教育厅科研项目(11511186)
关键词 小鼠 树突状细胞 抗原负载树突状细胞 抗肿瘤 形态学 Mouse dendritic cell (DC) antigen-loaded DC (ADC) antitumor morphology
  • 相关文献

参考文献9

  • 1RESCIGNO M, GRANUCCI F, RICCIARDI C P. Dendritic cells at the end of the millennium [ J ]. Immunol Cell Biol, 1999, 77 (5) : 404 -410.
  • 2CONRAD C, NESTLE F O. Dendritic cell - based cancer therapy [J]. Curr Opin Mol Ther,2003, 5(4) :405 -413.
  • 3谢遵江,贾立敏,贺业春,刘颖,刘丽.体外培养小鼠骨髓树突状细胞的扩增、鉴定及形态学观察[J].解剖科学进展,2005,11(3):240-243. 被引量:12
  • 4LIEBRICH W,SCHLAG P,MANASTERSKI M,et al. In vitro and clinical characterization of a newcastle disease virus - modified autologous tumor cell vaccine for treatment of colorectal cancer patients [J]. Eur J Cancer,1991, 27(6) :708 -710.
  • 5谢遵江,张云芳,刘颖,李益民,贺业春.人胃癌肿瘤浸润树突状细胞的形态学观察[J].解剖科学进展,2003,9(4):297-299. 被引量:6
  • 6BODEY B, BODEY J B, KAISER H E. Dendritic type, accessory cells within the mammalian thymic mieroenvironment, antigen presentation in the dendritic neuro - endocrine - immune cellular network [J]. In-Vivo, 1997, 11(4):351-361.
  • 7BUELENS C, WILLEMS F, DELVAUX A, et al. Interleukin- 10 differentially regulates B7 - 1 ( CD80 ) and B7 - 2 ( CD86 ) expression on human peripheral blood dendritic cells [ J ]. Eur J Immunol, 1995, 25(9) : 2668 -2672.
  • 8谢遵江,张云芳,刘丽,刘颖,贺业春.人直肠癌肿瘤浸润树突状细胞的形态学观察[J].解剖学报,2005,36(1):107-109. 被引量:2
  • 9HEISER A, COLEMAN D, DANNULL J, et al. Autologous dendritic cells transfected with prostate - specific antigen RNA stimulates CTL responses against metastatic prostate tumors [ J ]. J Clin Invest, 2002, 109 (3) : 409 -417.

二级参考文献17

  • 1[1]Mellmen I, Steinman RM. Dendritic cells specialized and regula ted antigen processing machines[J]. Cell, 2001, 106(3) :255 -258.
  • 2[2]Steinman RM, Cohn ZA. Identification of a novel cell type in pe ripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution [ J ]. J Exp Med, 1973, 137 (5): 1142 - 1162.
  • 3[3]Steinman RM. The dendritic cell system and its role in immunoge necity[ J]. Ann Rev Immunol, 1991, 9( 1 ) :217 -296.
  • 4[4]Wright-Browne V, Mcclain KL, Talpaz M, et al. Physiology and pathophysiology of dendritic cells [ J ]. Hum Pathol, 1997, 28 (5) :563 -579.
  • 5[5]Norbury CC, Chambers BJ, Prescott AR, et al. Constitutive mac ropinocytosis allows TAP-dependent major histocompatibility com plex class I presentation of exogenous soluble antigen by bone mar row-derived dendritic cell[J]. Eur J Immunol, 1997, 27( 1 ) :280 - 288.
  • 6[6]Santiage-Schwarz F, Borrero M, Tucci J, et al. In vitro expansion of CD+13, CD+33 dendritic cell precursors from multipotent progeni tors is regulated by a discrete fas-mediated apoptotic schedule[J]. J Leukoc Biol, 1997, 62(4) :493 -502.
  • 7[7]Gong J, Chen D, Kashiwaba M, et al. Induction ofantitumor activity by immunization with fusions of dendritic and carcinoma cells [J]. Nature Med, 1997, 3(5) :558 -561.
  • 8Steinman RM,Cohn ZA.Identification of a novel cel type in peripheral lymphoid organs of mice Ⅰ Morphology,quantitation tissue distribution [J].J Exp Med,1993,137(5):1142-1162.
  • 9Mellman Ⅰ,Steinman RM.Dendritic cells specialized and regulated antigen processing machines [J].Cell,2001,106(3):255-258.
  • 10Wright-Browen V,Mcclain KL,Talpaz M,et al.Physiology and pathophysiology of dendritic cells [J].Hum Pathol,1997,28(5):563-579.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部